Get started
Author

David Bernados

Observed institution: IGM Biosciences (United States)
OpenAlex ID: A5073740843
PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8+ T-cell Function
2019 · Sarah Whelan, Eran Ophir, et al. · Cancer Immunology Research · 149
COM902, a novel therapeutic antibody targeting TIGIT augments anti-tumor T cell function in combination with PVRIG or PD-1 pathway blockade
2021 · Kyle Hansen, Sandeep Kumar, et al. · Cancer Immunology Immunotherapy · 38
Novel CD123xCD3 Bispecific Igm Antibody, Igm-2537, Potently Induces T-Cell Mediated Cytotoxicity of Acute Myeloid Leukemia Cells In Vivo and in Vitro with Minimal Cytokine Release
2023 · Gene Li, Zhongde Ye, et al. · Blood · 2
Supplementary Figures and Tables from PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8+ T-cell Function
2023 · Sarah Whelan, Eran Ophir, et al.
Supplementary Figure Legends from PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8+ T-cell Function
2023 · Sarah Whelan, Eran Ophir, et al.
Data from PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8+ T-cell Function
2023 · Sarah Whelan, Eran Ophir, et al.
Supplementary Figure Legends from PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8+ T-cell Function
2023 · Sarah Whelan, Eran Ophir, et al.
Supplementary Figures and Tables from PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8+ T-cell Function
2023 · Sarah Whelan, Eran Ophir, et al.
Data from PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8+ T-cell Function
2023 · Sarah Whelan, Eran Ophir, et al.
Works count: 9
Citation count: 189
H-index: 2
I10-index: 2
Year
Topic
Type